Skip to main content
All lobbying filings

THE WASHINGTON TAX & PUBLIC POLICY GROUP

Lobbying for PFIZER, INC. · Pharmacetucial company

 Filing 4th Quarter - Report
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $30,000.00 income · posted Jan 20, 2026

Official filing document

 Bills named in this filing 7
  • HR 1990
    American Innovation and R&D Competitiveness Act of 2025
  • S 1639
    American Innovation and Jobs Act
  • HR 1062
    Growing and Preserving Innovation in America Act of 2025
  • HR 1347
    AIMM Act
  • S 559
    AIMM Act
  • S 1688
    Growing America’s Small Businesses and Manufacturing Act
  • HR 1
    An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
 Lobbying activity 1
Taxation/Internal Revenue Code

Issues related to corporate and international taxation. Issues related to OECD Pillar 1 and Pillar 2 negotiations and agreements on the taxation of global income. Issues related to IRC sections 11, 164(a), 951A, 250, 163(j), and 174. (H.R. 1990, S. 1639, H.R. 1062, H.R. 1347, S. 559, S. 1688, H.R. 1 - Sections 70321, 70322, 70323, 70303, 70302).

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem